Andover-based TransMedics Inc. closed on $25.5 million in private equity financing.
TransMedics is a medical technology company that develops organ transplant products.
The $25.5 million will help the company launch its Organ Care System in Europe and complete clinical trials on the system in the U.S.
Tudor Investments led the funding round.
According to the company, the system “is the first and only technology capable of maintaining a human organ in a warm, functioning, ‘living’ state outside the body.”
ADVERTISEMENT
The system offers the potential for increased availability of donor organs, the company said.
